FIELD: medicine; oncohematology; ophthalmology.
SUBSTANCE: invention is intended to predict the presence of ophthalmic disorders in chronic myeloid leukemia. The following data is obtained from the women suffering from chronic myeloproliferative disease: the age, duration of the disease, a complete blood count and coagulogram are conducted, the ESR and fibrinogen level. At the age of 48 years and older and the duration of the disease for more than 10 years, with hemoglobin values below 108 g/l and fibrinogen above 5.0 g/l, the presence of ophthalmic disorders is predicted.
EFFECT: invention provides a simple, effective method of predicting the presence of ophthalmic disorders in chronic myeloid leukemia.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTING THE PRESENCE OF PATHOLOGY OF THE VITREOMACULAR INTERFACE IN CHRONIC MYELOID LEUKEMIA | 2023 |
|
RU2803690C1 |
| METHOD OF PREDICTING THE PRESENCE OF CHORIOCAPILLARY PATHOLOGY IN THE PROJECTION OF THE MACULAR AREA IN CHRONIC MYELOPROLIFERATIVE DISEASES | 2022 |
|
RU2798930C1 |
| METHOD FOR DIAGNOSING ETIOLOGY OF UVEITIS AND PREDICTING NATURE OF COURSE | 2021 |
|
RU2755700C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF VASCULAR OR INFLAMMATORY LESION OF THE OPTIC DISC | 2022 |
|
RU2788393C1 |
| METHOD FOR PREDICTING EXACERBATION OF CHRONIC UVEITIS IN MEN WITH ANKYLOSING SPONDYLITIS | 2022 |
|
RU2782116C1 |
| METHOD FOR DIAGNOSING THE NEED TO PRESCRIBE GLUCOCORTICOIDS SYSTEMICALLY IN PATIENTS WITH RHEUMATIC DISEASE | 2021 |
|
RU2760260C1 |
| METHOD FOR PREDICTING ADVERSE PREGNANCY OUTCOMES IN WOMEN WITH TYPE 1 DIABETES MELLITUS IN THE SECOND HALF OF PREGNANCY | 2020 |
|
RU2759076C1 |
| METHOD FOR THE ETIOPATHOGENETIC TREATMENT OF PARAVASAL DISORDERS OF BULBAR CONJUNCTIVA IN PATIENTS WITH COVID-19 ASSOCIATED PNEUMONIA | 2021 |
|
RU2760297C1 |
| METHOD FOR DETERMINING THE NEED FOR PRESCRIBING ANTIBIOTIC THERAPY FOR UVEITIS | 2021 |
|
RU2762492C1 |
| DIAGNOSTIC TECHNIQUE OF DEGENERATIVE CORNEAL CHANGES IN PATIENTS SUFFERING RHEUMATOID ARTHRITIS DEPENDING ON RHEUMO-FACTOR INDICATOR | 2020 |
|
RU2733695C1 |
